The effects of ultrafiltration on e-aminocaproic acid: An in vitro analysis

Journal of Extra-Corporeal Technology

Volumn 34, Issue 3, 2002, Pages 197-202

  Petterson, Craig M ^a   Stammers, Alfred H ^a   Kohtz, Ryan J ^a   Kmiecik, Scott A ^a   Nichols, Jeffrey D ^a   Mills, Nancy J ^a   Liu, Jun Li ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

E aminocaproic acid; Fibrinolysis; Thromboelastograph; Ultrafiltration

Indexed keywords

AMINOCAPROIC ACID; UROKINASE;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DEVICE; DRUG EFFECT; FIBRINOLYSIS; IN VITRO STUDY; NONHUMAN; THROMBOELASTOGRAPHY; ULTRAFILTRATION;

EID: 0036746049     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mejak B, Stammers AH, Rauch E, Vang S, Viessman T. A retro-spective study on perfusion incidents and safety devices. Perfusion. 2000;15:51-61.
2. Bracey AW, Radovancevic R. The hematologic effects of cardipulmonary bypass and the use of hemotherapy in coronary artery bypass grafting. Arch Pathol Lab Med. 1994;118:411-6.
3. Arom KV, Emery RW. Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg. 1194;57:1108-13.
4. Fish SS, Pancorbo S, Berkseth R. Pharmacokinetics of epsilonaminocaproic acid during peritoneal dialysis. J Neurosurg. 1981;54: 736-9.
5. Del Rossi AJ, Cernaianu AC, Botros S, et al. Prophylactic treatment of postperfusion bleeding using EACA. Chest. 1989;96:27-32.
6. Golpher TA, Bennet WM. Drug removal by continuous arteriovenous hemofiltration. Med Toxicol Adverse Drug Exp. 1988;3:341-9.
7. Groom RC, Munoz R, McGowen K, et al. Ultrafiltration concentrates heparin. Proceed Am Acad Card Perf. 1996;17:83-5.
8. Holt DW, Landis GH, Dumond DA, Hardin SB, Bartosik J, Miller M. Hemofiltration as an adjunct to cardipulmonary bypass for total oxygenator volume control. J Extra Corp Tech. 1982;14:373-7.
9. Kohtz RJ, Petterson CM, Mills NJ, et al. Effects of ultrafiltration on enoxaparin: An in vitro analysis. J Extra Corp Tech. 2001;33:94-9.
10. Bonness AS, Stammers AH, Huffman SM, Ficek SJ, Brady CP. Evaluation of the thromboelastograph targeted coagulation assessment. J Extra Corp Tech. 1996;28:191-8.
11. Stammers AH, Willet L, Fristoe L, et al. Coagulation monitoring during extracorporeal membrane oxygenation: The role of thromboelastography. J Extra Corp Tech. 1995;27:137-45.
12. Golpher TA, Pulliam J, Bennet WM. Remocal of therapeutic drugs by continuous arteriovenious hemofiltration. Arch Intern Med. 1985; 145:1651-2.
13. Clar A, Larson DF. Hemofiltration: Determinants of drug loss and concentration. J Extra Corp Tech. 1995;27:158-63.
14. Frank RD, Farber H, Steffanidis, I, Lanzmich R, Kierdorf HP. Hirudin elimination by hemofiltration: a comparative in vitro study of different membranes. Kidney Int Supp. 1999;72:S41-5.
15. Frederiksen MC, Bowsher DJ, Ruo TI, et al. Kinetics of epsilonaminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther. 1984;35:387-93.
16. Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Williams Hematology, 6th ed. New York: McGraw-Hill;2001:1481.
17. Dentz ME, Slaughter TF, Mark JB. Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. Anesthesiology. 1995;82:583-6.
18. Hocker JR, Saving KL. Fatal aortic thrombosis in a neonate during infusion of epsilon-aminocaproic acid. J Ped Surg 1995;30:1490-2.
19. Sopher M, Braunfeld M, Shackleton, et al. Fatal pulmonary embolism during liver transplantation. Anesthesiology. 1997;87:429-32.
20. Plotkin JS, Johnson LB, Kuo PC. Intracardiac thrombus formation during orthotopic liver transplantation; a new entity or an old enemy. Transplant. 1996;61:1131.
21. Pitts TO, Spero JA, Bontempo FA, Greenburg A. Acute renal failure due to high-grade obstruction following therapy with epsilonaminocaproic acid. Am J Kidney Dis. 1986;8:441-4.
22. Tanaka M, Niizeki H, Miyakawa S. Contact dermatitis from epsilonaminocaproic acid. Contact Dermatitis. 1993;28:124.
23. Seymour BD, Rubinger M. Rhabdomyolysis induced by epsilonaminocaproic acid. Ann Pharmacother. 1997;31:56-8.
24. Winter SS, Chaffee S, Kahler SG, Graham ML. Epsilon-aminocaproic acid-associated myopathy in a child. J Ped Hematol/Oncol. 1995;17:53-5.
25. Glock R, Green D, Ts'ao C, Witt WA, Yu ATW, Raimondi AJ. High-dose epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Neurosurgery. 1981;9:398-401.